Think you might need to take out tax at 30% for a true EPS.
Nevertheless still at a big discount should all the assumptions about market size and penetration hold true.
Does anyone on the board have an opinion about the Bayer Xarelto competitor (think that's how you spell it?).
(Warning:This does not contitute investment advice as I am not very good at it.)
Think you might need to take out tax at 30% for a true...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TSN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| TSN (ASX) Chart |
Day chart unavailable